Dublin, April 01, 2022 (GLOBE NEWSWIRE) -- The "Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global empty capsules market reached a value of US$ 2.61 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 4.14 Billion by 2027 exhibiting a CAGR of 7.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Empty capsules refer to a stable shell encapsulating medicines that are administered in the patient's body in various dosage forms, such as granules and pellets. They are commercially available in two varying types, gelatin and non-gelatin. The gelatin capsules (hard and soft) are a high collagen animal-based medicine manufactured from pig meat and beef and chicken connective tissues. On the other hand, the non-gelatin, or vegetarian capsule, is produced from the blend of starch and hydroxypropyl methylcellulose (HPMC). Currently, empty capsules find extensive applications in healthcare and therapeutic applications.
Empty Capsules Market Trends:
The increasing prevalence of cardiovascular and chronic diseases and the rising geriatric population are some of the key factors driving the empty capsule market growth. In line with this, the introduction of capsule-in-capsule technology to ensure gastrointestinal safety of those patients that did not receive capsule medication is another growth-inducing factor. Moreover, the rising demand for the immediate-release capsule by manufacturers for producing various medicinal products, such as antibacterial, antiacids, inhalers, dietary supplements, painkillers, and antibiotics, are contributing to the market growth.
The rapid expansion in the healthcare industry and the widespread adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC) due to its moderate strength, transparency, and resistance to oil and fat properties, are propelling the market growth. Additionally, the increasing investments in the research and development (R&D) activities in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs is positively stimulating the market growth. Other factors, such as the easy access to advanced treatment options, strategic collaborations between the empty capsule suppliers and gelatin manufacturers, and the growing demand for various dietary supplements, immunity boosters, and drugs, are creating a positive outlook for the market.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global empty capsules market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, raw material, functionality, therapeutic application and end user.
Breakup by Type:
- Gelatin Capsule
- Non-gelatin Capsule
Breakup by Raw Material:
- Pig Meat
- Bovine Meat
- Bone
- Hydroxypropyl Methylcellulose (HPMC)
- Others
Breakup by Functionality:
- Immediate-release Capsules
- Sustained-release Capsules
- Delayed-release Capsules
Breakup by Therapeutic Application:
- Antibiotic and Antibacterial Drugs
- Vitamins and Dietary Supplements
- Antacid and Antiflatulent Preparations
- Cardiovascular Therapy Drugs
- Others
Breakup by End User:
- Pharmaceutical Industry
- Nutraceutical Industry
- Cosmetics Industry
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited.
Key Questions Answered in This Report:
- How has the global empty capsules market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global empty capsules market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the raw material?
- What is the breakup of the market based on the functionality?
- What is the breakup of the market based on the therapeutic application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global empty capsules market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Empty Capsules Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Gelatin Capsule
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Non-gelatin Capsule
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Raw Material
7.1 Pig Meat
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Bovine Meat
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Bone
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Hydroxypropyl Methylcellulose (HPMC)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Functionality
8.1 Immediate-release Capsules
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Sustained-release Capsules
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Delayed-release Capsules
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Therapeutic Application
9.1 Antibiotic and Antibacterial Drugs
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Vitamins and Dietary Supplements
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Antacid and Antiflatulent Preparations
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Cardiovascular Therapy Drugs
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by End User
10.1 Pharmaceutical Industry
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Nutraceutical Industry
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Cosmetics Industry
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
12 SWOT Analysis
13 Value Chain Analysis
14 Porters Five Forces Analysis
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 ACG Associated Capsules Pvt. Ltd.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Bright Pharma Caps Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 CapsCanada Corporation
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 HealthCaps India Limited
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Lonza Group AG
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Medicaps Limited
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation)
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Nectar Lifesciences Limited
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.9 Roxlor LLC
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Shanxi Guangsheng Medicinal Capsules Co. Ltd
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Snail Pharma Industry Co. Ltd
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 Suheung Co. Ltd
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.13 Sunil Healthcare Limited
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
For more information about this report visit https://www.researchandmarkets.com/r/os5asr
Attachment
